Skip to main content
. 2023 Aug 25;29(9):2216–2223. doi: 10.1038/s41591-023-02494-2

Extended Data Table 2.

Pharmacodynamic measurements of lipid parameters, results from post hoc analysis: MMRM percent change from baseline to day 113 compared to placebo for ANGPTL3, TG, non-HDL-C, VLDL-C, LDL-C and HDL-C in HPs receiving MADs of ARO-ANG3

graphic file with name 41591_2023_2494_Tab2_ESM.jpg